Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals

Morningside Pharmaceuticals add Mawdsleys as a distributor to Hospitals 4th March 2021

Mawdsleys is delighted to now be partnering with Morningside Pharmaceuticals as an additional distributor to supply their contract and non-contract products to hospitals.

Morningside has a portfolio of 242 generic and branded licensed medicines in the UK and EU and is a proud manufacturer and supplier to NHS Trusts, pharmacy chains, pharmaceutical wholesalers, as well as clinics and dispensing doctors in the UK.

Morningside’s products are available for customers to order now from Mawdsleys.

Other latest news

Mawdsleys announces new solus deal with M&A Pharmachem

Mawdsleys is delighted to announce a new solus hospital distribution agreement with M&A Pharmachem. From 1st July 2014, Mawdsleys will become the sole distributor for all M&A Pharmachem contracted products into the hospital sector, which previously hospitals purchased from M&A directly. As from this date, all orders for M&A products…

Cipla selects Mawdsleys as their UK distributor to hospitals

Mawdsleys is delighted to be partnering with Cipla to distribute their contract and non contract products to hospitals from 1st June 2020. Cameron McMaster, Associate Director UK Sales at Cipla says “We have chosen Mawdsleys to take full charge of our Hospital distribution due to their experience and reputation…